73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Molecular delivery system developed at URI shows promise against bladder cancer

Molecular delivery system developed at URI shows promise against bladder cancer

byUniversity of Rhode IslandpHLIP-ICG can locate cancerous lesions and illuminate them with a fluorescent molecule, making them potentially easier for surgeons to see and remove. Credit: URIA re

Molecular delivery system developed at URI shows promise against bladder cancer

byUniversity of Rhode IslandpHLIP-ICG can locate cancerous lesions and illuminate them with a fluorescent molecule, making them potentially easier for surgeons to see and remove. Credit: URIA re
Putting liquid biopsies on solid ground: Cancer diagnosis from a milliliter of blood

Putting liquid biopsies on solid ground: Cancer diagnosis from a milliliter of blood

byWeizmann Institute of ScienceSingle-molecule DNA sequencing technical setup. Schematic representation of key instrumentation used to perform single-molecule DNA sequencing. Straight and dashed

Putting liquid biopsies on solid ground: Cancer diagnosis from a milliliter of blood

byWeizmann Institute of ScienceSingle-molecule DNA sequencing technical setup. Schematic representation of key instrumentation used to perform single-molecule DNA sequencing. Straight and dashed
Machine-learning tool to match treatment for cancer patients

Machine-learning tool to match treatment for cancer patients

byTechnion - Israel Institute of TechnologySummary of pipeline predictions. a An overview of the RNA-MuTect-WMN pipeline: In the training set (n = 100, green arrows), RNA-MuTect is applied on tu

Machine-learning tool to match treatment for cancer patients

byTechnion - Israel Institute of TechnologySummary of pipeline predictions. a An overview of the RNA-MuTect-WMN pipeline: In the training set (n = 100, green arrows), RNA-MuTect is applied on tu
Noninvasive technique to assess brain tumors in children and make treatment less toxic

Noninvasive technique to assess brain tumors in children and make treatment less toxic

by Chris Speight,University of BirminghamCredit: CC0 Public DomainGround-breaking research by the University of Birmingham has discovered a new technique to assess the aggressiveness of childhoo

Noninvasive technique to assess brain tumors in children and make treatment less toxic

by Chris Speight,University of BirminghamCredit: CC0 Public DomainGround-breaking research by the University of Birmingham has discovered a new technique to assess the aggressiveness of childhoo
New insights into the drivers of glioma-related epilepsy

New insights into the drivers of glioma-related epilepsy

by Graciela Gutierrez,Baylor College of MedicineGraphical abstract. Credit:Neuron(2023). DOI: 10.1016/j.neuron.2023.01.013Glioma is one of the most aggressive malignant primary brain

New insights into the drivers of glioma-related epilepsy

by Graciela Gutierrez,Baylor College of MedicineGraphical abstract. Credit:Neuron(2023). DOI: 10.1016/j.neuron.2023.01.013Glioma is one of the most aggressive malignant primary brain
MicroRNA is the master regulator of the genome—researchers are learning how to harness the way it controls genes

MicroRNA is the master regulator of the genome—researchers are learning how to harness the way it controls genes

by Andrea Kasinski,The ConversationMicroRNA can silence genes by binding to mRNA. Credit:Kajsa Mollersen/Wikimedia Commons,CC BY-SAThe Earthformed 4.5 billion years ago, and li

MicroRNA is the master regulator of the genome—researchers are learning how to harness the way it controls genes

by Andrea Kasinski,The ConversationMicroRNA can silence genes by binding to mRNA. Credit:Kajsa Mollersen/Wikimedia Commons,CC BY-SAThe Earthformed 4.5 billion years ago, and li
WHO moves step closer to cheaper breast cancer treatment

WHO moves step closer to cheaper breast cancer treatment

The World Health Organization has approved a biosimilar version of Trastuzumab—the drug used to treat breast cancer—that is generally 65 percent cheaper than the originalThe World Health Organization

WHO moves step closer to cheaper breast cancer treatment

The World Health Organization has approved a biosimilar version of Trastuzumab—the drug used to treat breast cancer—that is generally 65 percent cheaper than the originalThe World Health Organization
Targeting epiregulin in treatment-damaged tumor microenvironment restrains therapeutic resistance

Targeting epiregulin in treatment-damaged tumor microenvironment restrains therapeutic resistance

by Liu Jia,Chinese Academy of SciencesGenotoxicity induces expression of EREG and other secreted factors of the SASP spectrum in human stromal cells.aTranscriptome-wide profiling of

Targeting epiregulin in treatment-damaged tumor microenvironment restrains therapeutic resistance

by Liu Jia,Chinese Academy of SciencesGenotoxicity induces expression of EREG and other secreted factors of the SASP spectrum in human stromal cells.aTranscriptome-wide profiling of
Oral paclitaxel yields better outcomes than intravenous paclitaxel for metastatic breast cancer

Oral paclitaxel yields better outcomes than intravenous paclitaxel for metastatic breast cancer

byAmerican Association for Cancer ResearchCredit: CC0 Public DomainMetastatic breast cancer patients who received an oral formulation of the chemotherapy drug paclitaxel had better response and

Oral paclitaxel yields better outcomes than intravenous paclitaxel for metastatic breast cancer

byAmerican Association for Cancer ResearchCredit: CC0 Public DomainMetastatic breast cancer patients who received an oral formulation of the chemotherapy drug paclitaxel had better response and
After Pembrolizumab/Lenvatinab Provides Clinical Benefit in Previously Treated Endometrial Cancer

After Pembrolizumab/Lenvatinab Provides Clinical Benefit in Previously Treated Endometrial Cancer

October 23, 2023Dylann Cohn-EmeryContinued treatment with lenvatinib monotherapy after the completeion of combination therapy with pembrolizumab and lenvatinib resulted in sustained clinical benefit v

After Pembrolizumab/Lenvatinab Provides Clinical Benefit in Previously Treated Endometrial Cancer

October 23, 2023Dylann Cohn-EmeryContinued treatment with lenvatinib monotherapy after the completeion of combination therapy with pembrolizumab and lenvatinib resulted in sustained clinical benefit v
Scientists find powerhouses that fight tumours from within

Scientists find powerhouses that fight tumours from within

In recent years doctors have turned to a new treatment for cancer, immunotherapy, which works by leveraging the body's own immune system to fight tumoursLurking deep inside some tumours are "

Scientists find powerhouses that fight tumours from within

In recent years doctors have turned to a new treatment for cancer, immunotherapy, which works by leveraging the body's own immune system to fight tumoursLurking deep inside some tumours are "
Enfortumab Vedotin Plus Pembrolizumab Generates Survival Benefit in Previously Untreated

Enfortumab Vedotin Plus Pembrolizumab Generates Survival Benefit in Previously Untreated

September 22, 2023Chris RyanTreatment with the combination of enfortumab Vedotin and pembrolizumab led to an improvement in overall survival and progression-free survival compared with chemotherapy in

Enfortumab Vedotin Plus Pembrolizumab Generates Survival Benefit in Previously Untreated

September 22, 2023Chris RyanTreatment with the combination of enfortumab Vedotin and pembrolizumab led to an improvement in overall survival and progression-free survival compared with chemotherapy in